Pigment Disorders
- Ruxolitinib Cream Results in Greater Repigmentation in Vitiligo
- Tranexamic Acid Treatment for Melasma
- Opzelura Cream Approved for Nonsegmental Vitiligo
- FDA Approves First Topical Treatment for Vitiligo
- Managing Patients With PIH and Skin of Color
- Post-Traumatic Stress in Patients With Vitiligo
- Topical Ruxolitinib Promising for Nonsegmental Vitiligo in Phase 3 Trials
- Patients With Vitiligo Have Increased Mental Health Burden
- The Autoimmune Link Between Vitiligo and Celiac Disease
- Consensus Statements Issued for Photoprotection for Skin of All Color
- Prevalence Estimates for Diagnosed, Undiagnosed Vitiligo in the US
- Colorimeter Detects Change in Vitiligo Lesions After 1 Month of Nb-UVB Treatment
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
